Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

September 1, 2021

Study Completion Date

September 30, 2023

Conditions
Inflammatory Bowel Diseases
Interventions
DEVICE

Intestinal ultra-sound monitoring

Children diagnosed with either CD or UC will be enrolled at diagnosis or at any time point during follow-up. Patients' characteristics will be retrieved from their medical files including demographic details, disease phenotype, endoscopic and radiologic variables, anthropometric measures, laboratory evaluation, complication and therapeutic regimens. At enrollment and every 3 months for a total period of 2 years all patients will perform intestinal US during regular clinic visits. All other measures including laboratory exams, anthropometric measurements and disease activity indices (either PCDAI for CD or PUCAI for UC) will be performed as part of standard of care.

Trial Locations (1)

4920235

Schenider Children's Medical Center, Petah Tikva

All Listed Sponsors
lead

Schneider Children's Medical Center, Israel

OTHER

NCT03026582 - Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter